The global flow cytometry services market size is calculated at USD 3.70 billion in 2025 and is expected to reach around USD 8.39 billion by 2034, growing at a CAGR of 9.77% for the forecasted period.
Ottawa, Nov. 14, 2025 (GLOBE NEWSWIRE) — The global flow cytometry services market size was valued at USD 3.37 billion in 2024 and is predicted to hit around USD 8.39 billion by 2034, rising at a 9.77% CAGR, a study published by Towards Healthcare a sister firm of Precedence Research. The global flow cytometry services market is driven by its expanding applications.
The Complete Study is Now Available for Immediate Access | Download the Sample Pages of this Report @ https://www.towardshealthcare.com/download-sample/5547
Key Takeaways
- North America held a major revenue share of the market in 2024.
- Asia Pacific is expected to witness the fastest growth in the flow cytometry services market during the forecast period.
- By accreditation type, the government segment held a major revenue share of the market in 2024.
- By accreditation type, the third-party accreditation segment is expected to witness significant growth in the market during the forecast period.
- By service type, the analysis segment held a major revenue share of the market in 2024.
- By service type, the general flow segment is expected to witness significant growth in the market during the forecast period.
What are the Flow Cytometry Services?
The flow cytometry services market is driven by increasing diseases, biopharmaceutical investments, and technological advancements. The flow cytometry services refer to the specialized laboratory and analytical services using flow cytometry technology for testing, cell sorting, or analysis. These services are used for disease diagnosis, immune system monitoring, cancer research, stem cell research, drug discovery and development, cell therapy development, quality control, microbial studies, and training.
What are the Major Drivers in the Flow Cytometry Services Market?
Expanding clinical research is the major driver in the market. This, in turn, is increasing the demand for flow cytometry services in immunology, stem cells, oncology research, and biomarker discovery, as well as for drug discovery, due to their precise, reliable, and high-throughput cell analysis. Additionally, the growth in personalized medicine, clinical diagnosis, outsourcing trends, cell-based therapies, and growing training programs are other market drivers.
You can place an order or ask any questions, please feel free to contact us at [email protected]
What are the Key Drifts in the Flow Cytometry Services Market?
The market has been expanding due to the growing collaborations and acquisitions, to launch and enhance the use of various flow cytometry services.
- In October 2025, a two-part research support initiative to enhance the accessibility of cell analysis, a collaboration between Cytek Biosciences and the International Society for Advancement of Cytometry, focusing on the adoption of cytometry technology, was announced.
- In June 2025, the successful acquisition of Cellular Highways Ltd, which is a biotechnology company with advanced cell sorting technologies and applications in cell and gene therapy, general cell research, and drug discovery, was announced by STEMCELL Technologies.
- In April 2025, a collaboration between 1Cell.Ai and BioSkryb Genomics was announced to develop and launch next-generation single-cell multi-omic solutions for the detection and characterization of rare mutations in single cells.
What is the Significant Challenge in the Flow Cytometry Services Market?
High cost acts as the major challenge in the market. The continuous use of reagents, instrument maintenance, and operational costs all limit the adoption of these services across smaller labs and limited infrastructure regions. Moreover, the growing operational complexities, shortage of skilled professionals, competition from alternative technologies, and regulatory challenges are other market restraints.
Regional Analysis
How did North America Dominate the Flow Cytometry Services Market in 2024?
In 2024, North America captured the biggest revenue share in the market, due to the presence of robust research infrastructure, which increases the use of these services in the research institutes, industries, and universities. They were also used for diagnostic applications and the development of personalized medicine by hospitals and industries. Moreover, the industries are developing advanced flow cytometry systems, which were backed by funding and investments, and also contributed to the market growth.
The U.S. Flow Cytometry Services Market Trends:
Due to the presence of strong healthcare infrastructure, the use of flow cytometry services in the U.S. is increasing. At the same time, the high healthcare spending and funding are driving their adoption across the pharmaceutical and biotechnology industries for drug discovery, cell therapy, and immunology. The growing diseases and R&D activities are also increasing the use of these services.
Become a valued research partner with us – https://www.towardshealthcare.com/schedule-meeting
The Canada Flow Cytometry Services Market Trends:
The expanding industries in Canada are increasing the use of flow cytometry services for R&D purposes. They are also being used in various labs for diagnostic applications. At the same time, the growing government initiatives and investments from various sources are being used to support their use in advanced cell technologies and life science research.
What Made Asia Pacific Grow Notably in the Flow Cytometry Services Market in 2024?
Asia Pacific is expected to host the fastest-growing cannabidiol market during the forecast period, due to growing R&D activities. At the same time, the growing incidence of cancer, infectious diseases, and immune-related diseases is increasing the use of these services for diagnostic purposes. The growing innovations, healthcare investments, and technological advancements are also increasing their use. Additionally, the growing collaborations and government support are promoting the market growth.
The China Flow Cytometry Services Market Trends:
The presence of advanced industries in China is increasing the use of flow cytometry services for R&D and diagnostic applications. They are also being used in the development of precision medicines and cell and gene therapies, which are backed by government initiatives. The growing outsourcing trends are also increasing their use.
The India Flow Cytometry Services Market Trends:
The growing advancements in research and development across various industries are increasing the demand for flow cytometry services. Additionally, the expanding infrastructure is driving the adoption of diagnostic tools, which is encouraging the use of these services. Furthermore, the government initiatives are supporting their use to accelerate the clinical trials.
Get the latest insights on life science industry segmentation with our Annual Membership: https://www.towardshealthcare.com/get-an-annual-membership
Segmental Insights
By accreditation analysis
Which Accreditation Type Segment Held the Dominating Share of the Flow Cytometry Services Market in 2024?
By accreditation type, the government segment held the dominating share of the market in 2024, due to its strict quality and safety standards. At the same time, they offered uniform protocols for labs, which helped in reducing the data variability. Moreover, they ensured consistent public health monitoring, where these factors promoted the use of flow cytometry services.
By accreditation type, the third-party accreditation segment is expected to show lucrative growth in the market during the predicted time, due to its rapid certification process. They also offer internationally recognized certifications, which encourage global collaborations. Additionally, they can customize the standards depending on the applications, such as cell therapy, single-cell analysis, or immune-oncology.
By service analysis
What Made Analysis the Dominant Segment in the Flow Cytometry Services Market in 2024?
By service type, the analysis segment led the market in 2024, as it is important for the detection of cell populations, immune responses, and biomarkers. They were also required for the interpretation of the multidimensional datasets generated. This, in turn, increased the adoption of various analytical software and tools for diagnostic purposes and data analysis.
By service type, the general flow segment is expected to show notable growth in the market during the upcoming years, due to its wide range of research, clinical testing, and diagnostic applications. They also offer more accessible and affordable flow cytometry services. Additionally, the growing routine testing demand is also increasing their use.
Recent Developments in the Flow Cytometry Services Market
- In April 2025, for high-resolution, single-cell profiling and cytokine analysis, a next-generation Cytometry by Time-Of-Flight (CyTOF) Inflammatory Response Assay was launched by Aliri Bioanalysis.
- In April 2025, the Beacon Discovery™ Optofluidic System, providing an accessible entry point into live single-cell functional analysis, was launched by Bruker Corporation.
Browse More Insights of Towards Healthcare:
The global small molecule API market size is calculated at US$ 206.9 billion in 2025, grew to US$ 219.52 billion in 2026, and is projected to reach around US$ 374.03 billion by 2035. The market is expanding at a CAGR of 6.1% between 2026 and 2035.
The global infant nutrition market size is calculated at USD 60.1 billion in 2025, grew to USD 66.2 billion in 2026, and is projected to reach around USD 158.11 billion by 2035. The market is expanding at a CAGR of 10.15% between 2026 and 2035.
The global cell-based assays market size began at US$ 17.29 billion in 2024 and is forecast to rise to US$ 18.82 billion by 2025. By the end of 2034, it is expected to surpass US$ 39.92 billion, growing steadily at a CAGR of 8.84%.
The strand displacement amplification (SDA) market size touched US$ 1.66 billion in 2025, with expectations of climbing to US$ 1.73 billion in 2026 and hitting US$ 2.45 billion by 2035, driven by a CAGR of 3.96% over the forecast period.
The global biologics contract research organization market size is calculated at USD 31.15 billion in 2024, will grow to USD 35.22 billion in 2025, and is projected to reach around USD 106.28 billion by 2034, reflecting a CAGR of 13.04%.
The global liquid biopsy market size is projected to reach USD 23.94 billion by 2034, growing from USD 7.08 billion in 2025, at a CAGR of 14.5% during the forecast period from 2025 to 2034.
The global artificial intelligence in life sciences market size was calculated at USD 2.25 billion in 2024, to reach USD 2.71 billion in 2025 is expected to be worth USD 14.20 billion by 2034, expanding at a CAGR of 20.21% from 2024 to 2034.
The global biopharmaceuticals market size was calculated at USD 421.58 billion in 2024, to reach USD 474.28 billion in 2025 is expected to be worth USD 1369 billion by 2034, expanding at a CAGR of 12.5% from 2024 to 2034.
The global antibodies drug market size was calculated at USD 272.3 billion in 2025, to reach USD 301.71 billion in 2026 is expected to be worth USD 759.36 billion by 2035, expanding at a CAGR of 10.8% from 2026 to 2035.
The global ambulatory healthcare services market size was calculated at USD 928.95 billion in 2025, to reach USD 979.21 billion in 2026 is expected to be worth USD 1492.54 billion by 2035, expanding at a CAGR of 5.41% from 2026 to 2035.
Flow Cytometry Services Market Key Players List
- Q2 Solutions
- Bio-Legend
- Flow Contract Sites Laboratory
- FlowMetric Life Sciences
- MLM Medical Labs
- ProImmune
- Firalis
- Unilabs
- Life Science Research
- ACROBIOsystems
- Ardena
- Agilex Biolabs
- CHOP Research Institute
- Cell flow cytometry
- Research Lab Services
- Fluorescence
- Proimmune
- Aurelia Bioscience
- Plant Cytometry services
- Bio-Rad Laboratories
- FACS Services
- Beckman Coulter
- Sphere Fluidics Limited
- IBR Inc.
- Icon plc
- Rockland-inc
- NeoGenomics
- ACM Global Laboratories
- Charles River Laboratories
- ReachBio
- RayBiotech
- Mdbiosciences
- CSI Laboratories
- ProMab
- Creative Proteomics
- Covance
Segments Covered in The Report
By Accreditation Type
- Government
- Third-Party Accreditation
By Service Type
- General Flow Cytometric Service
- Assay Development
- Consumables Manufacturing
- Analysis
- PBMC Analysis
- Whole Blood Cells Analysis
- Bone Marrow Aspirate Analysis
- Stem Cells Analysis
- Rare Cells Detection
- Cell Profiling and subset
- Intracellular staining
By Region
North America
- U.S.
- Canada
- Mexico
- Rest of North America
South America
- Brazil
- Argentina
- Rest of South America
Europe
- Western Europe
- Germany
- Italy
- France
- Netherlands
- Spain
- Portugal
- Belgium
- Ireland
- UK
- Iceland
- Switzerland
- Poland
- Rest of Western Europe
- Eastern Europe
- Austria
- Russia & Belarus
- Türkiye
- Albania
- Rest of Eastern Europe
Asia Pacific
- China
- Taiwan
- India
- Japan
- Australia and New Zealand,
- ASEAN Countries (Singapore, Malaysia)
- South Korea
- Rest of APAC
MEA
- GCC Countries
- Saudi Arabia
- United Arab Emirates (UAE)
- Qatar
- Kuwait
- Oman
- Bahrain
- South Africa
- Egypt
- Rest of MEA
Immediate Delivery Available | Buy This Premium Research @ https://www.towardshealthcare.com/checkout/5547
Access our exclusive, data-rich dashboard dedicated to the healthcare market – built specifically for decision-makers, strategists, and industry leaders. The dashboard features comprehensive statistical data, segment-wise market breakdowns, regional performance shares, detailed company profiles, annual updates, and much more. From market sizing to competitive intelligence, this powerful tool is one-stop solution to your gateway.
Access the Dashboard: https://www.towardshealthcare.com/access-dashboard
About Us
Towards Healthcare is a leading global provider of technological solutions, clinical research services, and advanced analytics, with a strong emphasis on life science research. Dedicated to advancing innovation in the life sciences sector, we build strategic partnerships that generate actionable insights and transformative breakthroughs. As a global strategy consulting firm, we empower life science leaders to gain a competitive edge, drive research excellence, and accelerate sustainable growth.
You can place an order or ask any questions, please feel free to contact us at [email protected]
Europe Region: +44 778 256 0738
North America Region: +1 8044 4193 44
APAC Region: +91 9356 9282 04
Web: https://www.towardshealthcare.com
Our Trusted Data Partners
Precedence Research | Statifacts | Towards Packaging | Towards Automotive | Towards Food and Beverages | Towards Chemical and Materials | Towards Consumer Goods | Towards Dental | Towards EV Solutions | Nova One Advisor | Healthcare Webwire | Packaging Webwire | Automotive Webwire | Nutraceuticals Func Foods | Onco Quant | Sustainability Quant | Specialty Chemicals Analytics
Find us on social platforms: LinkedIn | Twitter | Instagram | Medium | Pinterest
Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same.